| 2023 |
Persistent high prevalence of modifiable cardiovascular risk factors among patients with osteoarthritis in the UK in 1992-2017
10.1136/rmdopen-2023-003298
Authors: D. Yu, X. Huang, M. Mamas, R. Wilkie |
| 2023 |
Persistent inequalities in consultation incidence and prevalence of low back pain and osteoarthritis in England between 2004 and 2019
10.1093/rap/rkac106
Authors: D. Yu, K. Jordan, R. Wilkie, J. Bailey, J. Fitzpatrick, N. Ali, P. Niblett, G. Peat |
| 2020 |
Persistent postoperative pain and healthcare costs associated with instrumented and non-instrumented spinal surgery: a case-control study
10.1186/s13018-020-01633-6
Authors: S. Weir, M. Samnaliev, T. Kuo, T. Tierney, A. Manca, R. Taylor, J. Bruce, S. Eldabe, D. Cumming |
| 2024 |
Persons diagnosed with COVID-19 in England in the Clinical Practice Research Datalink (CPRD): a cohort description
10.1136/bmjopen-2023-073866
Authors: K. Andersen, L. McGrath, M. Reimbaeva, D. Mendes, J. Nguyen, K. Rai, T. Tritton, C. Tsang, D. Malhotra, J. Yang |
| 2004 |
Pharmaceutical treatment of symptomatic vertebral fractures in primary care
10.1136/ard.2003.013508
Authors: D. Torgerson, D. Sykes, S. Puffer, P. Brown, C. Cooper |
| 2019 |
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing
10.1371/journal.pone.0218115
Authors: J. Floyd, K. Bloch, J. Brody, C. Maroteau, M. Siddiqui, R. Gregory, D. Carr, M. Molokhia, X. Liu, J. Bis, A. Ahmed, X. Liu, P. Hallberg, Q . Y. Yue, P. Magnusson, D. Brisson, K. Wiggins, A. Morrison, E. Khoury, P. McKeigue, B. Stricker, M. Lapeyre-Mestre, S. Heckbert, A. Gallagher, H. Chinoy, R. Gibbs, E. Bondon-Guitton, R. Tracy, E. Boerwinkle, D. Gaudet, A. Conforti, T. Van Staa, C. Sitlani, K. Rice, A. van der Zee, M. Wadelius, A. Morris, M. Pirmohamed, C. Palmer, B. Psaty, A. Alfirevic |
| 2017 |
Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events
10.2337/dc17-0595
Authors: A. Douros, H. Yin, O. H. Y. Yu, K. Filion, L. Azoulay, S. Suissa |
| 2023 |
Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP-4 inhibitors: population-based cohort study
10.1002/cpt.2975
Authors: J. Dimakos, Y. Cui, R. Platt, C. Renoux, K. Filion, A. Douros |
| 2018 |
Pharmacological intervention in hypertension using beta-blockers: Real-world evidence for long-term effectiveness
10.1016/j.phrs.2018.01.010
Authors: M. Sabido, T. Hohenberger, G. Grassi |
| 2023 |
Pharmacologically Treated Anxiety and Depression in People Diagnosed with von Willebrand Disease: Matched Cohort Study
10.2147/jbm.s407993
Authors: K. Hagberg, S. Jick, G. Ozen, P. Du |
| 2016 |
Pharmacosurveillance without borders: electronic health records in different countries can be used to address important methodological issues in estimating the risk of adverse events
10.1016/j.jclinepi.2016.03.033
Authors: R. Tamblyn, N. Girard, W. Dixon, J. Haas, D. Bates, T. Sheppard, T. Eguale, D. Buckeridge, M. Abrahamowicz, A. Forster |
| 2015 |
Pharmacotherapeutic strategies for patients treated for depression in UK primary care: a database analysis
10.1185/03007995.2015.1020362
Authors: F. Lamy, J. Chollet, E. Clay, M. Brignone, B. Rive, D. Saragoussi |
| 2023 |
Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold
10.1371/journal.pdig.0000383
Authors: M. Barclay, C. Renzi, A. Antoniou, S. Denaxas, H. Harrison, S. Ip, N. Pashayan, A. Torralbo, J. Usher-Smith, A. Wood, G. Lyratzopoulos |
| 2016 |
Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink
10.1371/journal.pmed.1002037
Authors: A. Matthews, S. Langan, I. Douglas, L. Smeeth, K. Bhaskaran |
| 2016 |
Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer
10.1016/j.eururo.2016.04.035
Authors: Y. Lian, H. Yin, M. Pollak, S. Carrier, R. Platt, S. Suissa, L. Azoulay |
| 2010 |
Phynx: an open source software solution supporting data management and web-based patient-level data review for drug safety studies in the general practice research database and other health care databases
10.1002/pds.1860
Authors: M. Egbring, G. Kullak-Ublick, S. Russmann |
| 2006 |
Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database
10.1111/j.1365-2036.2006.03044.x
Authors: R. Jones, R. Latinovic, J. Charlton, M. Gulliford |
| 2017 |
Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer
10.1370/afm.2100
Authors: A. Farley, C. Koshiaris, J. Oke, R. Ryan, L. Szatkowski, R. Stevens, P. Aveyard |
| 2013 |
Physicians\textquoteright prescribing preferences were a potential instrument for patients\textquoteright actual prescriptions of antidepressants
10.1016/j.jclinepi.2013.06.008
Authors: N. Davies, D. Gunnell, K. Thomas, C. Metcalfe, F. Windmeijer, R. Martin |
| 2015 |
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
10.1007/s00125-014-3456-9
Authors: D. Levin, S. Bell, R. Sund, S. Hartikainen, J. Tuomilehto, E. Pukkala, I. Keskimaki, E. Badrick, A. Renehan, I. Buchan, S. Bowker, J. Minhas-Sandhu, Z. Zafari, C. Marra, J. Johnson, B. Stricker, A. Uitterlinden, A. Hofman, R. Ruiter, C. de Keyser, T. MacDonald, S. Wild, P. McKeigue, H. Colhoun |
| 2013 |
Pioglitazone and bladder cancer: a propensity score matched cohort study
10.1111/j.1365-2125.2012.04325.x
Authors: L. Wei, T. MacDonald, I. Mackenzie |
| 2018 |
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study
10.1136/bmjdrc-2017-000481
Authors: H. Strongman, S. Christopher, M. Majak, R. Williams, S. Bahmanyar, M. Linder, E. Heintjes, D. Bennett, P. Korhonen, F. Hoti |
| 2017 |
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study
10.1136/bmjdrc-2016-000364
Authors: H. Strongman, P. Korhonen, R. Williams, S. Bahmanyar, F. Hoti, S. Christopher, M. Majak, L. Kool-Houweling, M. Linder, P. Dolin, E. Heintjes |
| 2016 |
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
10.1136/bmj.i3903
Authors: P. Korhonen, E. Heintjes, R. Williams, F. Hoti, S. Christopher, M. Majak, L. Kool-Houweling, H. Strongman, M. Linder, P. Dolin, S. Bahmanyar |
| 2016 |
Pioglitazone use and risk of bladder cancer: population based cohort study
10.1136/bmj.i1541
Authors: M. Tuccori, K. Filion, H. Yin, O. Yu, R. Platt, L. Azoulay |
| 2016 |
PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term - a cluster randomised controlled trial and economic evaluation
10.3310/hta20930
Authors: S. Julious, M. Horspool, S. Davis, M. Bradburn, P. Norman, N. Shephard, C. Cooper, W. Smithson, J. Boote, H. Elphick, A. Loban, M. Franklin, W. Kua, R. May, J. Campbell, R. Williams, S. Rex, O. Bortolami |
| 2006 |
Pneumococcal polysaccharide vaccine uptake in England, 1989-2003, prior to the introduction of a vaccination programme for older adults
10.1093/pubmed/fdl017
Authors: K. Noakes, R. Pebody, U. Gungabissoon, J. Stowe, E. Miller |
| 2020 |
Pneumococcal vaccine coverage among individuals aged 18 to 64 years old with underlying medical conditions in the UK: a retrospective database analysis
10.1186/s12889-020-09613-5
Authors: I. Matthews, X. Lu, Q. Xia, W. Black, B. Nozad |
| 2019 |
Pneumonia incidence trends in UK primary care from 2002 to 2017: population-based cohort study
10.1017/s0950268819001559
Authors: X. Sun, A. Douiri, M. Gulliford |
| 2014 |
Point-of-care cluster randomized trial in stroke secondary prevention using electronic health records
10.1161/strokeaha.114.005713
Authors: A. Dregan, T. van Staa, L. McDermott, G. McCann, M. Ashworth, J. Charlton, C. Wolfe, A. Rudd, L. Yardley, M. Gulliford, Committee Steering |
| 2018 |
Poisoning substances taken by young people: a population-based cohort study
10.3399/bjgp18X698897
Authors: E. Tyrrell, D. Kendrick, K. Sayal, E. Orton |
| 2018 |
Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory
10.1038/s41398-018-0186-7
Authors: A. Cherskov, A. Pohl, C. Allison, H. Zhang, R. Payne, S. Baron-Cohen |
| 2022 |
Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England
10.1186/s12916-022-02473-3
Authors: A. Subramanian, S. Lee, K. Phillips, K. Toulis, P. Kempegowda, M. O'Reilly, N. Adderley, S. Thangaratinam, W. Arlt, K. Nirantharakumar |
| 2018 |
Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes
10.1210/jc.2017-02667
Authors: T. Berni, C. Morgan, E. Berni, D. Rees |
| 2021 |
Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses
10.1371/journal.pmed.1003498
Authors: L. Sun, L. Pennells, S. Kaptoge, C. Nelson, S. Ritchie, G. Abraham, M. Arnold, S. Bell, T. Bolton, S. Burgess, F. Dudbridge, Q. Guo, E. Sofianopoulou, D. Stevens, J. Thompson, A. Butterworth, A. Wood, J. Danesh, N. Samani, M. Inouye, E. Di Angelantonio |
| 2023 |
Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data
10.3399/bjgp.2022.0295
Authors: A. Jeffery, C. Bhanu, K. Walters, I. Wong, D. Osborn, J. Hayes |
| 2023 |
Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019
10.1186/s12916-022-02722-5
Authors: A. Subramanian, A. Azcoaga-Lorenzo, A. Anand, K. Phillips, S. Lee, N. Cockburn, A. Fagbamigbe, C. Damase-Michel, C. Yau, C. McCowan, D. O'Reilly, G. Santorelli, H. Hope, J. Kennedy, K. Abel, K. Eastwood, L. Locock, M. Black, M. Loane, N. Moss, R. Plachcinski, S. Thangaratinam, S. Brophy, U. Agrawal, Z. Vowles, P. Brocklehurst, H. Dolk, C. Nelson-Piercy, K. Nirantharakumar |
| 2019 |
Polypharmacy patterns in the last year of life in patients with dementia
10.1007/s00228-019-02721-1
Authors: R. Denholm, R. Morris, R. Payne |
| 2024 |
Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases
10.1136/bmjopen-2022-070258
Authors: D. Dedman, R. Williams, K. Bhaskaran, I. Douglas |
| 2018 |
Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia
10.1530/eje-17-0895
Authors: S. Jenkins-Jones, L. Parviainen, J. Porter, M. Withe, M. Whitaker, S. Holden, C. Morgan, C. Currie, R. Ross |
| 2015 |
Poorly controlled type 2 diabetes mellitus is associated with a decreased risk of incident gout: a population-based case-control study
10.1136/annrheumdis-2014-205337
Authors: S. Bruderer, M. Bodmer, S. Jick, C. Meier |
| 2002 |
Population need for coronary revascularisation: are national targets for England credible?
Authors: R. Martin, H. Hemingway, D. Gunnell, K. Karsch, A. Baumbach, S. Frankel |
| 2016 |
Population prevalence of Down\textquoterights syndrome in the United Kingdom
10.1111/jir.12277
Authors: M. Alexander, Y. Ding, N. Foskett, H. Petri, C. Wandel, O. Khwaja |
| 2017 |
Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014
10.1136/bmjopen-2016-014444
Authors: R. Mathur, K. Bhaskaran, E. Edwards, H. Lee, N. Chaturvedi, L. Smeeth, I. Douglas |
| 2017 |
Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013
10.1093/rheumatology/kex270
Authors: D. Yu, K. Jordan, J. Bedson, M. Englund, F. Blyth, A. Turkiewicz, D. Prieto-Alhambra, G. Peat |
| 2018 |
Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa
10.1111/bjd.16101
Authors: J. Ingram, S. Jenkins-Jones, D. Knipe, C. Morgan, R. Cannings-John, V. Piguet |
| 2014 |
Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes
10.1136/bmjopen-2013-003839
Authors: A. Gallagher, T. van Staa, T. Murray-Thomas, N. Schoof, A. Clemens, D. Ackermann, D. Bartels |
| 2024 |
Population-based study of alcohol-related liver disease in England 2001-2018: Influence of socioeconomic position
10.14309/ajg.0000000000002677
Authors: G. Askgaard, P. Jepsen, M. Jensen, A. Kann, J. Morling, F. Kraglund, T. Card, C. Crooks, J. West |
| 2013 |
Population-based study of presentation and adverse outcomes after femoral hernia surgery
10.1002/bjs.9336
Authors: D. Humes, R. Radcliffe, C. Camm, J. West |
| 2000 |
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom
Authors: C. Meier, P. Napalkov, Y. Wegmuller, T. Jefferson, H. Jick |
